Bayer wins second Roundup cancer case in California


By Ed Frankl

Bayer AG said Thursday that a California jury had concluded that its Roundup weedkiller was not the cause of a woman’s cancer.

The result is the German pharmaceutical and chemical conglomerate’s second victory for its pesticide glyphosate, after a jury in Los Angeles ruled in favor of Bayer for the first time in October. Bayer has lost its first three cases involving Roundup.

The San Bernardino court ruled in favor of the company, after Donetta Stephens said she suffered from non-Hodgkin lymphoma after using Roundup herbicide for more than 30 years.

“The jury’s verdict in favor of the company concludes this lawsuit successfully and is consistent with the evidence in this case that Roundup is not the cause of Ms. Stephens’ cancer. Although we have great sympathy for Ms. Stephens We agree with the jury that Roundup is not the cause of his illness, ”a Bayer spokesperson said.

Bayer maintains that Roundup, which it acquired in the $ 63 billion buyout of agrochemicals company Monsanto, does not cause cancer.

The Leverkusen, Germany-based company hopes a U.S. Supreme Court ruling in a separate case will help end a multi-year weedkiller dispute.

“The company continues to defend the safety of Roundup and will confidently defend the safety of our product as well as our good faith actions in any future litigation,” Bayer said.

Legal issues surrounding Roundup prompted the company to set aside billions in provisions to settle cases.

Write to Ed Frankl at edward.frankl@dowjones.com

-0-


Comments are closed.